Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator.

Gondcaille C, Depreter M, Fourcade S, Lecca MR, Leclercq S, Martin PG, Pineau T, Cadepond F, ElEtr M, Bertrand N, Beley A, Duclos S, De Craemer D, Roels F, Savary S, Bugaut M.

J Cell Biol. 2005 Apr 11;169(1):93-104. Epub 2005 Apr 4.

2.

Dehydroepiandrosterone up-regulates the Adrenoleukodystrophy-related gene (ABCD2) independently of PPARalpha in rodents.

Gueugnon F, Gondcaille C, Leclercq S, Bellenger J, Bellenger S, Narce M, Pineau T, Bonnetain F, Savary S.

Biochimie. 2007 Nov;89(11):1312-21. Epub 2007 Jul 6.

PMID:
17686565
3.

Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha.

Fourcade S, Savary S, Albet S, Gauthé D, Gondcaille C, Pineau T, Bellenger J, Bentejac M, Holzinger A, Berger J, Bugaut M.

Eur J Biochem. 2001 Jun;268(12):3490-500.

4.

ABCD2 is a direct target of β-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapy.

Park CY, Kim HS, Jang J, Lee H, Lee JS, Yoo JE, Lee DR, Kim DW.

PLoS One. 2013;8(2):e56242. doi: 10.1371/journal.pone.0056242. Epub 2013 Feb 21.

5.

Evaluation of the therapeutic potential of PPARalpha agonists for X-linked adrenoleukodystrophy.

Rampler H, Weinhofer I, Netik A, Forss-Petter S, Brown PJ, Oplinger JA, Bugaut M, Berger J.

Mol Genet Metab. 2003 Dec;80(4):398-407.

PMID:
14654352
7.

Induction of the adrenoleukodystrophy-related gene (ABCD2) by thyromimetics.

Genin EC, Gondcaille C, Trompier D, Savary S.

J Steroid Biochem Mol Biol. 2009 Aug;116(1-2):37-43. doi: 10.1016/j.jsbmb.2009.04.006. Epub 2009 May 3.

PMID:
19406244
8.

Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.

Singh J, Olle B, Suhail H, Felicella MM, Giri S.

J Neurochem. 2016 Jul;138(1):86-100. doi: 10.1111/jnc.13562. Epub 2016 Mar 14.

9.

Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.

Weinhofer I, Forss-Petter S, Zigman M, Berger J.

Hum Mol Genet. 2002 Oct 15;11(22):2701-8.

PMID:
12374760
10.

Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.

McGuinness MC, Zhang HP, Smith KD.

Mol Genet Metab. 2001 Sep-Oct;74(1-2):256-63.

PMID:
11592822
11.

Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.

Netik A, Forss-Petter S, Holzinger A, Molzer B, Unterrainer G, Berger J.

Hum Mol Genet. 1999 May;8(5):907-13.

PMID:
10196381
12.

Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2).

Genin EC, Geillon F, Gondcaille C, Athias A, Gambert P, Trompier D, Savary S.

J Biol Chem. 2011 Mar 11;286(10):8075-84. doi: 10.1074/jbc.M110.211912. Epub 2011 Jan 5.

13.
14.

Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2).

Fourcade S, Savary S, Gondcaille C, Berger J, Netik A, Cadepond F, El Etr M, Molzer B, Bugaut M.

Mol Pharmacol. 2003 Jun;63(6):1296-303.

15.

Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.

Kemp S, Wei HM, Lu JF, Braiterman LT, McGuinness MC, Moser AB, Watkins PA, Smith KD.

Nat Med. 1998 Nov;4(11):1261-8.

PMID:
9809549
16.

X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.

Kemp S, Wanders RJ.

Mol Genet Metab. 2007 Mar;90(3):268-76. Epub 2006 Nov 7. Review.

PMID:
17092750
17.

Topology of ATP-binding domain of adrenoleukodystrophy gene product in peroxisomes.

Contreras M, Sengupta TK, Sheikh F, Aubourg P, Singh I.

Arch Biochem Biophys. 1996 Oct 15;334(2):369-79.

PMID:
8900413
18.

Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders.

Corzo D, Gibson W, Johnson K, Mitchell G, LePage G, Cox GF, Casey R, Zeiss C, Tyson H, Cutting GR, Raymond GV, Smith KD, Watkins PA, Moser AB, Moser HW, Steinberg SJ.

Am J Hum Genet. 2002 Jun;70(6):1520-31. Epub 2002 Apr 29.

19.

X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype.

Maier EM, Mayerhofer PU, Asheuer M, Köhler W, Rothe M, Muntau AC, Roscher AA, Holzinger A, Aubourg P, Berger J.

Biochem Biophys Res Commun. 2008 Dec 5;377(1):176-80. doi: 10.1016/j.bbrc.2008.09.092. Epub 2008 Oct 1.

PMID:
18834860
20.

Supplemental Content

Support Center